# FDA Inspection 650331 - McKesson Corporation dba RxPak - March 01, 2010

Source: https://www.globalkeysolutions.net/records/fda_inspections/mckesson-corporation-dba-rxpak/0e09a648-088a-4e9e-a4e9-0e6dc10899b7/
Source feed: FDA_Inspections

> FDA Inspection 650331 for McKesson Corporation dba RxPak on March 01, 2010. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 650331
- Company Name: McKesson Corporation dba RxPak
- Inspection Date: 2010-03-01
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1046405 - 2018-03-22](https://www.globalkeysolutions.net/api/records/fda_inspections/mckesson-corporation-dba-rxpak/95128efc-57ed-4764-b2ee-a98c44065eae/)
- [FDA Inspection 984729 - 2016-07-27](https://www.globalkeysolutions.net/api/records/fda_inspections/mckesson-corporation-dba-rxpak/ff09fd5a-8906-41b6-a175-95f00bbd6460/)

Company: https://www.globalkeysolutions.net/companies/mckesson-corporation-dba-rxpak/d65f7265-a6b2-409b-958a-a69365e81ded

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c